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Abstract
The present study aimed to examine the effects of thyroid hormone (TH), more precisely triiodothyronine (T3), on the
modulation of leptin mRNA expression and the involvement of the phosphatidyl inositol 3 kinase (PI3K) signaling
pathway in adipocytes, 3T3-L1, cell culture. We examined the involvement of this pathway in mediating TH effects by
treating 3T3-L1 adipocytes with physiological (P=10nM) or supraphysiological (SI=100 nM) T3 dose during one hour
(short time), in the absence or the presence of PI3K inhibitor (LY294002). The absence of any treatment was
considered the control group (C). RT-qPCR was used for mRNA expression analyzes. For data analyzes ANOVA
complemented with Tukey’s test was used at 5% significance. T3 increased leptin mRNA expression in P (2.26 ±
0.36, p< 0.001), SI (1.99 ±0.22, p< 0.01) compared to C group (1± 0.18). This increase was completely abrogated by
LY294002 in P (1.31±0.05, p< 0.001) and SI (1.33±0.31, p< 0.05). Western blotting confirmed these results at protein
level, indicating the PI3K pathway dependency. To examine whether leptin is directly induced by T3, we used the
translation inhibitor cycloheximide (CHX). In P, the presence of CHX maintained the levels mRNA leptin, but was
completely abrogated in SI (1.14±0.09, p> 0.001). These results demonstrate that the activation of the PI3K signaling
pathway has a role in TH-mediated direct and indirect leptin gene expression in 3T3-L1 adipocytes.
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Introduction
Thyroid hormones (THs) actions are especially important
during development, this actions regulate the growth and
maturation of many organs and tissues during the fetal and
neonatal life [1,2]. Many tissues are regulated by THs up to
their complete development, including actions on groups of
genes involved in the differentiation program. The adipose
tissue (AT) is an important target for THs. The AT is
specialized in the transport, synthesis, storage, and
mobilization of lipids. Its main function is the storage of energy
in the form of triglycerides, and it constitutes a reservoir of
energy to be used in times of caloric deprivation [3]. AT is the
largest endocrine organ in the body, secreting hormones,
chemokines, and cytokines (commonly referred to
as adipokines) that are important paracrine/endocrine
regulators [4].
The leptin is an AT product and together with THs are
involved in the energy balance [5]. TH status also influences
leptin, various studies try to correlate leptin with TH [6].
Administration of 3,5,3’- triiodothyronine (T3) to hypothyroid
rats also decreased leptin mRNA expression in adipose tissue
and circulating leptin levels [7]. However, in other reports, THs
up-regulate leptin in differentiated adipocytes. T3, but not
thyroxine (T4), stimulated ob mRNA expression and leptin
secretion in 3T3-L1 adipocytes [8], cells in which leptin
expression is less than 1% of intact adipose tissue.
Additionally, human studies show no conclusive evidence on
the relationship between TH and leptin levels [9,10].
The presence of thyroid hormone receptors (TRs) in AT
suggests that there might be a direct interference of the thyroid
activity in the production of adipokines at AT [11]. Studies in a
microarray investigation, showed that the THs regulates 19
genes from humans white AT [12]. These genes originate
PLOS ONE | www.plosone.org 1 September 2013 | Volume 8 | Issue 9 | e74856
proteins that are involved in signal transduction, lipid
metabolism, apoptosis, and inflammatory responses.
Studies from our group showed that a T3 physiological dose
increases leptin gene expression in obese animals subjected to
diet restriction [13]. However, animals subjected to
supraphysiological doses of T3 showed a diminishment in
leptin mRNA expression [14]. These findings suggest that THs
physiological levels might be necessary for the adequate leptin
secretion [13]. Notwithstanding, our methodology did not
enable us to verify if THs acts directly on AT modulating leptin
expression.
The concept regarding the THs action has been diversified,
including non-classical actions of T3 and T4. T3 has been
shown as an activator of the phosphatidyl inositol 3-kinase
(PI3K), which leads to an increase in certain genes, such as
Hypoxia-inducible factor 1 (HIF-1α) and calcineurin inhibitor
(ZAKI-4α) [15,16]. Hence, the present study assessed the
effect of physiological and supraphysiological T3 doses in
leptin mRNA and protein expression levels at 3T3-L1,
adipocytes culture, after one hour of treatment.
We have evaluated the influence of protein synthesis in the
leptin transcription rate regulated by T3 using the translation-
inhibitor cycloheximide (CHX). LY294002 was used to check if
the non-classical pathway (PI3K) was involved in the T3 action
in the leptin mRNA levels. We have found that T3 increases the
leptin expression levels in one hour (short time) of treatment,
and such increase occurs directly in T3 physiological dose and
indirectly in supraphysiological dose, but both depend on the
activation of PI3K pathway.
Materials and Methods
2.1: Chemicals and antibodies
Isobutylmethylxanthine (IBMX), dexamethasone, insulin,
cycloheximide (CHX), triiodothyronine (T3), LY294002 (LY),
Dimethyl Sulfoxide (DMSO), Sodium hydroxide (NaOH) and
Charcoal Stripped fetal bovine serum (FBS) were purchased
from Sigma (St Louis, MO, USA). Dulbecco’s modified Eagle’s
medium (DMEM), fetal bovine serum and Antibiotic-Antimycotic
100X solution were purchased from Gibco BRL (Grand Island,
NY, USA). The Rabbit polyclonal to leptin antibody (AB9749)
and the mouse monoclonal GAPDH antibody (AB97069) were
obtained from ABCAM (Abcam, Cambridge, UK). The anti-
rabbit and anti-mouse secondary antibodies were purchased
from Santa Cruz Biotechnology (CA, USA). Enhanced
chemiluminescence (ECL) reagents were obtained Amersham
Biosciences (NJ, USA).
2.2 Cell culture and differentiation
Mouse 3T3-L1 preadipocytes were obtained from the Cell
Bank of Rio de Janeiro (Rio de Janeiro, RJ, Brazil), and were
grown in polystyrene six-well plates, at 37°C in DMEM
supplemented with 10% FBS (Sigma), and 1% Antibiotic-
Antimycotic 100X solution (Gibco). After cell conﬂuence
(designated as day 0), differentiation was initiated with 1µg/ml
insulin, 1µM dexamethasone (DEX), and 0.5 mM IBMX in
DMEM containing 10% FBS. After a 4-day incubation the
culture media were replaced by DMEM supplemented with
10% FBS and 1 µg/ml insulin, and the cells were then fed every
two days with DMEM containing 10% FBS. 3T3-L1 cells were
fully differentiated by day 8. After differentiation, cells were
incubated for 24 hour in DMEM supplemented with 10%
Charcoal Stripped FBS (to deplete T3) and 1 µg/ml insulin.
After incubation, cells were treated with: either physiological T3
dose (10 nM, named P group) or supraphysiological T3 dose
(100 nM, named SI group) during one hour (1h). A non-treated
group, only 0.1% NaOH (diluent T3), was used as control (C).
For the one-hour time period, it was also formed groups of P
and SI added with CHX (10µg/ml) [16] and groups that were
added with LY (50µM) [16]. The inhibitors LY294002 and CHX
were added to the medium 1 h before T3 treatment.
2.3: Oil red O staining
3 T3-L1 cells were grown on 6-well plates and induced to
differentiate as previously described. After an 8-day incubation
(day 8), plates were twice washed with phosphate-buffered
saline (PBS), ﬁxed with 37% formaldehyde during 30 minutes
at room temperature, and then washed twice again with PBS.
After ﬁxation, cells were stained for 2h at room temperature
with a ﬁltered of oil red O solution (0.5 g oil red O (Sigma) in
100 ml isopropanol), washed twice with distilled water and
visualized to confirm differentiation.
2.4: Gene expression
Total RNA was extracted from 3T3-L1 cells by Trizol
(Invitrogen) method, according to the manufacturer’s
instructions. The High Capacity cDNA reverse transcription kit
for RT-PCR® (Invitrogen, São Paulo, Brazil) was used for the
synthesis of 20 µL complementary DNA (cDNA) from 1000 ng
of whole RNA.
Leptin (assay Mm00434759_m1*- Applied Biosystems)
levels were determined by RT-qPCR. Quantitative
measurements were made in the “Applied Biosystems
StepOne Plus” detection system using the TaqMan qPCR
commercial kit (Invitrogen) according to the manufacturer’s
instructions. Cycling conditions were as follows: enzyme
activation at 50°C during 2 min, denaturation at 95°C during 10
min, cDNA products were ampliﬁed during 40 cycles of
denaturation at 95°C during 15 s and annealing/extension at
60°C during 1 min. Gene expression was quantified in relation
to the values of the C group after normalization by an internal
control, cyclophilin (Mm00434759_m1), by the 2 − ΔΔCt method,
as previously described [17].
2.5: Western blot analysis
Following treatment with T3, cells were washed twice with
cold PBS, and lysed with 100 µl of lysis buffer containing 500
mM Tris (pH 8), 150 mM NaCl, 1% Triton X-100, 0.1% sodium
dodecyl sulfate (SDS), and 0.5% deoxycholate of sodium. The
homogenate was centrifuged at 4°C for 20 minutes at 12000
rpm. The supernatant was collected and total protein content
was determined by the Bradford Method [18] using Albumin
Serum Bovine (BSA) as standard. Samples containing 50 µg of
protein were subjected to 15% SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) in polyacrylamide gels. After
electrophoresis, proteins were electro-transferred to
Triiodothyronine upon mRNA/Protein Leptin Levels
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nitrocellulose membrane using a semidry transfer system
(BioRad Biosciences; NJ, USC). The blotted membrane was
then blocked 5% BSA in Tris buffered saline (TBS) with 0.1%
Tween-20 (T) for 1 h at room temperature (RT) and incubated
with specific antibodies overnight at 4°C. The primary
antibodies used were rabbit polyclonal anti-leptin 1: 5000 and
mouse monoclonal anti-GAPDH 1: 1000. After incubation with
secondary anti-rabbit (1: 1000) and anti-mouse (1: 10000) in
5% BSA in TBS-T for 1h RT, blots were developed using the
SuperSignal West Pico Chemiluminescent Substrate kit
(Pierce) and exposed to Hyperﬁlm ECL (Amersham
Bioscieneces). Quantitative analysis of immunoblot images
was performed using Gel Logic (6000 PRO) with Carestream
MI software. Results are shown as the squared pixels ratio
between leptin and GAPDH, and represented as fold activation
relatively to cells exposed to assay media.
2.6: Statistical analysis
Gene expression was analyzed using the analysis of
variance (ANOVA) followed by Tukey’s test. Data are
expressed as mean ± standard deviation. The significance
level was set at 5%.
Results
3.1: 3T3-L1 cell culture and differentiation
Figure 1A presents 3T3-L1 cells before differentiation. In the
presence of a differentiation mix (insulin, dexamethasone, and
IBMX) the pre-adipocytes turn into adipocytes presenting the
morphology of mature adipocytes (Figure 1B and 1C), whose
main characteristic is the presence of a great amount of
cytoplasmic lipid droplets. Oil red O makes these droplets more
evident and lipids are stained red (1C).
3.2: Leptin mRNA and protein levels increase after one
hour of T3 incubation
Figure 2 shows that T3 increased the levels of leptin mRNA
(Figure 2A) and protein (Figure 2B) in 3T3-L1 adipocytes in P
and SI if compared to the C group after one hour of incubation.
3.3: The increase of Leptin mRNA and protein induced
by T3 action is sensitive to LY294002
In order to check if PI3K pathway is involved in the mediation
of leptin mRNA and protein expression after one hour of
incubation with T3, groups P and SI were treated with a PI3K
inhibitor (LY294002). Figure 3 shows that the addition of LY to
different T3 doses led to the diminishment of leptin expression
that were increased in P and SI (Figure 3A, B, C and D).
3.4: Effects of the protein synthesis inhibition upon the
modulation of T3 induced leptin mRNA levels
In order to determine the need of protein synthesis for T3
regulation of leptin mRNA levels after one hour of treatment,
groups P and SI were incubated with CHX. The addition of
CHX to the P group did not change the levels of leptin mRNA
(Figure 4A). However, CHX decreased the mRNA leptin levels
in SI (Figure 4B).
Discussion
Since the adipose tissue is a target of thyroid hormones
[19,20], some authors suggest that the leptin and thyroid might
have a parallel response [21]. However, many studies
investigating the possible relationship between thyroid
hormone and leptin levels, reported conflicting results.
Whereas some studies show no association between leptin
serum concentration and thyroid hormone levels [6,22,23],
others report a negative [24,25] or a positive correlation
[26,27]. These divergent results may occur due to the use of
different models, which demonstrate that THs might have
different actions according to the model and the systemic
factors involved. Thus, the present study aims to elucidate the
AT response to different T3 doses on leptin mRNA expression
without the interference of systemic factors.
Experimental model of 3T3-L1 cells (embryonic Mus
musculus cells) (Figure 1A) were differentiated in vitro into
adipocytes (Figure 1B and C). These cells represent a well-
established adipogenesis model [28]. Our findings suggest that
T3 has rapid effects in the modulation of leptin expression,
since P and SI showed an increase in leptin gene expression
(Figure 2A) and protein (Figure 2B) after 1 hour of T3
Figure 1.  3T3-L1 cells before and after their differentiation into adipocytes.  A) Non-differentiated cells. B) Cells with ten days
of differentiation. C) Cells in oil red O after ten days differentiation. Arrows show adipocyte with cytoplasmic lipid droplet.
doi: 10.1371/journal.pone.0074856.g001
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incubation. These results agree with the findings of Yoshida et
al. [8], who were the first to measure the leptin secretion levels
in 3T3-L1 cells in the presence of T3. However, they have
observed an increase in leptin mRNA levels after 24 hours of
incubation. Expression of leptin increases during adipocyte
differentiation, and peaks as mature adipocytes fill with lipids
[29] and in Jiang et al. [30] showed that administration of T3 to
the diﬀerentiating 3T3-L1 cells enhanced the accumulation of
triglyceride.
At physiological concentration of 10nM of T3, administered to
the P group, there was na increased in both mRNA expression
and secretion of leptin. Findings of Luvizotto et al. [13] suggest
Figure 2.  Dose-response for T3 effects upon leptin mRNA
expression and protein in 1h. P =10 nM T3, SI = 100 nM T3,
C = without T3.  A) T3 effects in leptin mRNA expression by
10 nM and 100 nM doses. B) T3 effects in leptin protein by 10
nM and 100 nM doses. Data expressed in average and
standard deviation (ANOVA supplemented with Tukey’s test).
n.s = non-significant; n = 3 in each treatment.
doi: 10.1371/journal.pone.0074856.g002
that physiologic levels of thyroid hormone are necessary for
appropriate leptin expression and this dose of T3 could be
used safely in the treatment of obesity because, at this level,
T3 increases the expression of leptin, a hormone with central
actions that cause a reduced food intake and an increase in
energy expenditure, but does not decrease body protein.
Several studies have shown that neither chronic
hyperthyroidism nor acute T3 treatment has affected serum
leptin levels [31,32]. In the study of Luvizotto et al. [14,33], the
supraphysiological dose of 50 fold greater than physiological
levels, signiﬁcantly reduced leptin gene expression. In
hyperthyroid patients, plasma leptin levels were unaffected by
treatment for 12–28 weeks with methimazole [34]. These data
indicate that, in humans, the plasma leptin status in individuals
with relatively low plasma leptin levels is little affected by
thyroid status. However, Yoshida et al. [8] and the present
study reported that T3 enhanced the accumulation of leptin
mRNA as well as leptin release by mouse 3T3-L1 cells, in
supraphysiological concentration of 100nM of T3. One reason
for the difference between in vivo and in vitro expressions is
due the fact that leptin expression levels in 3T3-L1 and 3T3-
F442A cells is less than 1% compared to intact adipose tissue
[35,36].
It is known that THs may act by mechanisms other than the
classical TRs/Thyroid Hormone Responsive Elements (TREs)
[15]. These mechanisms can be called non-classical or non-
genomic because their initiation sites may be in the plasma
membrane, like the activation of integrin αvβ3 pathway, or in
the cytoplasm, where the TH activates the mitogen-activated
protein kinase (MAPK) or PI3K pathway. The initiation sites are
proteins that are characterized as iodothyronine receptors
[16,37].
PI3K participates in a wide variety of cellular process,
including intracellular trafficking, organization of the
cytoskeleton, cell growth and transformation, and prevention of
apoptosis [38,39]. PI3K has a role in differentiation of several
cell lines [40,41], including adipocytes.
We used specific inhibitor of PI3K, LY294002, signaling
cascades regarding leptin expression, because T3 have been
reported to activation at these signaling pathways to modulate
specifics genes [15,16]. It was observed that leptin mRNA and
protein levels that were T3-increased in P and SI, were then
suppressed by the presence of LY294002 (Figure 3A, B, C and
D), without cell toxicity. These findings strongly suggest that
up-regulation of leptin gene transcription is mediated via the
PI3K pathway by T3.
In order to check if the T3 action was direct or indirect upon
the modulation of leptin gene, it was used a protein synthesis
inhibitor in parallel with the use of a PI3K pathway inhibitor.
The addition of CHX, which is a protein synthesis inhibitor,
induced a leptin mRNA levels diminishment in group SI (Figure
4B), indicating that the effects of T3 upon this gene need
protein synthesis prior to transcription. Under physiological T3
dose (group P) the CHX did not display any effect in leptin
mRNA (Figure 4A), indicating that T3 has direct action upon
the leptin mRNA expression increase. To our knowledge, this is
the first study using CHX to determine the direct/indirect action
of T3 upon the levels of leptin.
Triiodothyronine upon mRNA/Protein Leptin Levels
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In summary, these data suggest that physiological and
supraphysiological dose of T3 increase leptin mRNA
expression after one hour of incubation without the
characterization of a dose-dependent event. After one hour of
T3 treatment, there is a direct increase in leptin levels when
using physiological dose, whereas supraphysiological dose
show an indirect leptin levels increase that depends on the
PI3K pathway activation. Since leptin is an important
adipostatic signal to the brain and it was observed that it is
modulated by T3 through the activation of PI3K cytosolic
pathway, the understanding of its mechanism of action is of
utter importance.
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